Press releases | Finanzwire

Basculer en Français

11231	Companies
249170	Keywords
177124	Articles
134989	Press releases

Home
Press releases

PRESS RELEASE

published on 07/30/2025 at 14:30, 1 year 2 months ago

Measles Cases Increasing Worldwide, Need the New NV-387 Broad-Spectrum Antiviral to Combat, Says NanoViricides
NanoViricides introduces drug candidate NV-387 as a potential treatment for Measles outbreak. The drug has shown safety and effectiveness in animal studies and Phase I trial, aiming to combat the global epidemic

NanoViricides NV-387 Antiviral Vaccination Measles
PRESS RELEASE

published on 07/30/2025 at 14:29, 1 year 2 months ago

INSIDE INFORMATION / OTHER NEWS RELEASES
Medincell's partner Teva Pharmaceuticals raises 2025 revenue outlook for UZEDY® to $190–$200M and confirms Olanzapine LAI on track for submission in 2025

Revenue Outlook Medincell Teva Pharmaceuticals Olanzapine LAI Submission
PRESS RELEASE

published on 07/30/2025 at 14:25, 1 year 2 months ago

Forward Water Technologies Announces Financial Results for the Fifteen-Month Period Ended March 31, 2025
Forward Water Technologies Corp. (FWTC) releases financial results for the fifteen-month period ended March 31, 2025. CEO discusses successful trial with iFO™ process and plans for technology expansion

Financial Results Forward Water Technologies Corp. Technology Expansion IFO™ Process Publicly Traded
PRESS RELEASE

published on 07/30/2025 at 14:00, 1 year 2 months ago

GameSquare's Stream Hatchet Publishes 2025 Q2 Live Streaming Trends Report
Global live streaming viewership grew 5% YoY to 9.1 billion hours in Q2 2025, reaching highest level since 2021, as per Stream Hatchet report by GameSquare Holdings

GameSquare Holdings Stream Hatchet Live Streaming Viewership Q2 2025
PRESS RELEASE

published on 07/30/2025 at 14:00, 1 year 2 months ago

Stabilis Solutions Announces Second Quarter 2025 Conference Call and Webcast Date
Stabilis Solutions, Inc. to issue Q2 2025 results on August 6, 2025, with a conference call on August 7, 2025, to discuss financial results and recent events

Financial Results Conference Call Investor Relations Stabilis Solutions Q2 2025 Results
PRESS RELEASE

published on 07/30/2025 at 14:00, 1 year 2 months ago

Nextech3D.AI Reports Audited Financial Results; 55% Gross Profit Growth and 58% Reduction in Operating Cash Burn
Nextech3D.AI Corp. announces improved financial results for the 15-month period ended March 31, 2025, showing increased gross profit, margin, and operational efficiencies. CEO Gappelberg highlights margin expansion and recurring revenue growth strategy

Financial Results Nextech3D.ai Recurring Revenue AI-powered Solutions Margin Expansion
PRESS RELEASE

published on 07/30/2025 at 14:00, 1 year 2 months ago

EonX Signs Partnership with PartsCheck to Launch Automotive Industry Payments & Loyalty Solution
EonX Technologies Inc. partners with PartsCheck to launch 'PartsPay', an innovative payments solution rewarding business customers with points in the automotive industry. The agreement aims to redefine transactions and create value in the supply chain

Automotive Industry Loyalty Program EonX Technologies Inc. PartsCheck Payments Solution
PRESS RELEASE

published on 07/30/2025 at 13:42, 1 year 2 months ago

Inside Information / Other news releases
Medincell's partner Teva increases 2025 revenue outlook for UZEDY® to $190–$200M, plans olanzapine LAI submission. Company's innovative treatments aim to improve medicine accessibility

Revenue Outlook Medincell Teva Pharmaceuticals Olanzapine LAI UZEDY
PRESS RELEASE

published on 07/30/2025 at 13:30, 1 year 2 months ago

Salzgitter AG sells DESMA Schuhmaschinen GmbH to NAME & MAWI Partners S.A.S.
Salzgitter AG sells DESMA Schuhmaschinen GmbH to NAME & MAWI Partners S.A.S., furthering portfolio management strategy. Transaction to be completed in autumn 2025

Acquisition Portfolio Management Salzgitter AG DESMA Schuhmaschinen GmbH NMP Group
PRESS RELEASE

published on 07/30/2025 at 13:30, 1 year 2 months ago

MIRA Pharmaceuticals Reports New Topical Ketamir-2 shows comparable effects to Injected Morphine in Preclinical Pain Study
MIRA Pharmaceuticals announces new preclinical data showing topical Ketamir-2 provides effective pain relief comparable to injected morphine in animal models. The treatment has potential for both centralized and localized pain pathways

Preclinical Data MIRA Pharmaceuticals Ketamir-2 Neuropathic Pain Topical Pain Relief

Accesswire

Published on 10/27/2026 at 11:00, 46 minutes ago

Camino and Nittetsu Launch Next Phase of Detailed Engineering for the Puquios Copper Project in Chile with Ausenco
Published on 10/27/2026 at 11:00, 46 minutes ago

Pivotree to Release Third Quarter 2026 Financial Results
Published on 10/27/2026 at 11:00, 46 minutes ago

High Tide Resources Reports 99.8 Metres of 31.7% Fe from Labrador West Iron Project
Published on 10/27/2026 at 08:01, 3 hours 45 minutes ago

Star Copper Expands Historical Copper System with Largest Drill Program in Project History with Pervasive Mineralization Across Multiple Intercepts
Published on 10/27/2026 at 01:00, 10 hours 46 minutes ago

Mining Exploration Entity or Oil and Gas Exploration Entity Quarterly Cash Flow Report

View all ACCESSWIRE

EQS Group

Published on 10/27/2026 at 10:30, 1 hour 16 minutes ago

Amundi Index Solutions: NOTICE TO SHAREHOLDERS
Published on 10/27/2026 at 10:15, 1 hour 31 minutes ago

OSCP unveils MK2Z-3, a photonic IMU with up to three photonic gyro axes, at Silicon Valley Space Week
Published on 10/27/2026 at 10:15, 1 hour 31 minutes ago

CEOTRONICS received a framework agreement worth approximately €1 million
Published on 10/27/2026 at 10:00, 1 hour 46 minutes ago

EPH Group AG: Building Permit Granted for Exclusive Boutique Hotel at Lake Tegernsee
Published on 10/27/2026 at 09:58, 1 hour 48 minutes ago

EQS-Adhoc: Mercedes-Benz Group AG adjusts its full-year 2026 outlook based on effects expected in the fourth quarter

Les Echos

Published on 10/26/2026 at 18:11, 17 hours 35 minutes ago

Declaration of transactions on own shares from October 19, 2026 to October 25, 2026
Published on 10/26/2026 at 17:45, 18 hours 1 minute ago

Weekly share buyback
Published on 10/26/2026 at 17:30, 18 hours 16 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of September 30, 2026
Published on 10/26/2026 at 07:30, 1 day 4 hours ago

EURAZEO’S SUPERVISORY BOARD APPOINTS CHRISTOPHE BAVIÈRE AS CHAIRMAN OF THE EXECUTIVE BOARD AND CEO
Published on 10/23/2026 at 20:33, 3 days 15 hours ago

Disclosure of transactions in own shares from October 19 to October 23, 2026

View all LES ECHOS COMFI WIRE